Cite
HARVARD Citation
Xu, R. et al. (n.d.). 1150PRecombinant humanized anti-PD-1 monoclonal antibody (JS001) in patients with refractory/metastatic nasopharyngeal carcinoma: Preliminary results of an open-label phase II clinical study. Annals of oncology. p. . [Online].